Henry Schein, Inc. (0L3C.L)
0L3C.L Stock Price Chart
Explore Henry Schein, Inc. interactive price chart. Choose custom timeframes to analyze 0L3C.L price movements and trends.
0L3C.L Company Profile
Discover essential business fundamentals and corporate details for Henry Schein, Inc. (0L3C.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Equipment & Services
IPO Date
29 Jan 2018
Employees
25.00K
Website
https://www.henryschein.comCEO
Stanley M. Bergman CPA
Description
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
0L3C.L Financial Timeline
Browse a chronological timeline of Henry Schein, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 May 2026
Upcoming earnings on 23 Feb 2026
Upcoming earnings on 4 Nov 2025
Revenue estimate is $3.28B.
Earnings released on 5 Aug 2025
EPS came in at $0.70 falling short of the estimated $1.19 by -41.09%, while revenue for the quarter reached $3.24B , missing expectations by -1.09%.
Earnings released on 5 May 2025
EPS came in at $1.15 surpassing the estimated $1.11 by +3.60%, while revenue for the quarter reached $3.17B , missing expectations by -1.68%.
Earnings released on 25 Feb 2025
EPS came in at $0.75 falling short of the estimated $1.20 by -37.67%, while revenue for the quarter reached $3.19B , missing expectations by -2.18%.
Earnings released on 5 Nov 2024
EPS came in at $0.78 falling short of the estimated $1.17 by -33.42%, while revenue for the quarter reached $3.17B , missing expectations by -5.60%.
Earnings released on 6 Aug 2024
EPS came in at $0.81 falling short of the estimated $1.22 by -33.77%, while revenue for the quarter reached $3.14B , missing expectations by -4.00%.
Earnings released on 7 May 2024
EPS came in at $0.72 falling short of the estimated $1.02 by -29.71%, while revenue for the quarter reached $3.17B , missing expectations by -1.05%.
Earnings released on 27 Feb 2024
EPS came in at $0.14 falling short of the estimated $0.70 by -80.22%, while revenue for the quarter reached $3.02B , missing expectations by -0.64%.
Earnings released on 13 Nov 2023
EPS came in at $1.04 falling short of the estimated $1.32 by -21.21%, while revenue for the quarter reached $3.16B , missing expectations by -1.57%.
Earnings released on 7 Aug 2023
EPS came in at $1.06 falling short of the estimated $1.28 by -17.19%, while revenue for the quarter reached $3.10B , missing expectations by -0.83%.
Earnings released on 9 May 2023
EPS came in at $0.91 falling short of the estimated $1.23 by -26.02%, while revenue for the quarter reached $3.06B , missing expectations by -0.96%.
Earnings released on 16 Feb 2023
EPS came in at $0.35 falling short of the estimated $1.22 by -71.65%, while revenue for the quarter reached $3.37B , beating expectations by +0.50%.
Earnings released on 29 Sept 2022
EPS came in at $1.09 falling short of the estimated $1.14 by -4.39%, while revenue for the quarter reached $3.07B , missing expectations by -3.86%.
Earnings released on 29 Jun 2022
EPS came in at $1.15 surpassing the estimated $1.13 by +1.77%, while revenue for the quarter reached $3.03B , missing expectations by -2.92%.
Earnings released on 26 Mar 2022
EPS came in at $1.30 surpassing the estimated $1.19 by +9.24%, while revenue for the quarter reached $3.18B , beating expectations by +2.47%.
Earnings released on 15 Feb 2022
EPS came in at $1.05 surpassing the estimated $0.92 by +13.64%, while revenue for the quarter reached $3.33B , beating expectations by +5.61%.
Earnings released on 2 Nov 2021
EPS came in at $1.10 , while revenue for the quarter reached $2.97B .
Earnings released on 25 Sept 2021
EPS came in at $1.10 , while revenue for the quarter reached $3.18B .
Earnings released on 27 Mar 2021
EPS came in at $1.16 , while revenue for the quarter reached $2.92B .
Earnings released on 26 Dec 2020
EPS came in at $0.99 , while revenue for the quarter reached $3.17B .
Earnings released on 26 Sept 2020
EPS came in at $0.99 , while revenue for the quarter reached $2.84B .
0L3C.L Stock Performance
Access detailed 0L3C.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.